Restatement of Previously Issued Consolidated Statement of Operation (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands |
3 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2024 |
Jun. 30, 2024 |
Mar. 31, 2024 |
Sep. 30, 2023 |
Jun. 30, 2023 |
Mar. 31, 2023 |
Jun. 30, 2024 |
Jun. 30, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||
| Revenue, net | $ 12,295 | $ 12,042 | $ 10,178 | $ 9,203 | $ 11,045 | $ 9,655 | $ 22,219 | $ 20,701 | $ 34,515 | $ 29,904 | $ 46,926 | $ 40,036 |
| Cost of revenue | 4,393 | 4,236 | 3,867 | 3,821 | 3,826 | 3,514 | 8,102 | 7,340 | 12,496 | 11,161 | 17,001 | 14,980 |
| Gross profit | 7,902 | 7,806 | 6,311 | 5,382 | 7,219 | 6,141 | 14,117 | 13,361 | 22,019 | 18,743 | 29,925 | 25,056 |
| Operating expenses: | ||||||||||||
| Sales and marketing | 2,864 | 2,887 | 2,821 | 2,498 | 2,605 | 2,342 | 5,707 | 4,947 | 8,571 | 7,444 | 11,655 | 10,233 |
| Research and development | 199 | 146 | 137 | 149 | 186 | 149 | 283 | 335 | 483 | 484 | 676 | 636 |
| General and administrative | 2,538 | 2,141 | 2,239 | 2,124 | 2,894 | 2,494 | 4,381 | 5,389 | 6,918 | 7,515 | 9,486 | 9,363 |
| Acquisition related amortization expense | 199 | 318 | 318 | 635 | 834 | 861 | ||||||
| Change in fair value of contingent consideration | 7 | |||||||||||
| Total operating expenses | 5,601 | 5,174 | 5,197 | 4,970 | 6,003 | 5,303 | 10,371 | 11,306 | 15,972 | 16,277 | 21,817 | 21,100 |
| Operating income from continuing operations | 2,301 | 2,632 | 1,114 | 412 | 1,216 | 838 | 3,746 | 2,055 | 6,047 | 2,466 | 8,108 | 3,956 |
| Interest accretion expense | (19) | (35) | (30) | (66) | (34) | (92) | (34) | (112) | ||||
| Note payable interest expense | (625) | (896) | ||||||||||
| Other expense, net | (499) | (667) | ||||||||||
| Income from continuing operations before tax | 1,762 | 2,515 | 816 | (96) | 783 | 597 | 3,331 | 1,380 | 5,093 | 1,284 | 6,950 | 2,281 |
| Provision for income taxes | 4 | 4 | 4 | 4 | 4 | 4 | 8 | 8 | 12 | 12 | 4 | 17 |
| Income from continuing operations | 1,758 | 2,511 | 812 | (100) | 779 | 593 | 3,323 | 1,372 | 5,081 | 1,272 | 6,946 | 2,264 |
| Loss from discontinued operations, net of tax | (82) | (74) | (104) | (86) | (220) | (79) | (178) | (299) | (260) | (385) | (244) | (310) |
| Net income | $ 1,676 | $ 2,437 | $ 708 | $ (186) | $ 559 | $ 514 | $ 3,145 | $ 1,073 | $ 4,821 | $ 887 | $ 6,702 | $ 1,954 |
| Basic net income (loss) per share of common stock: | ||||||||||||
| From continuing operations | $ 0.40 | $ 0.57 | $ 0.19 | $ (0.02) | $ 0.18 | $ 0.14 | $ 0.76 | $ 0.32 | $ 1.16 | $ 0.29 | $ 1.48 | $ 0.52 |
| From discontinued operations | (0.02) | (0.02) | (0.02) | (0.02) | (0.05) | (0.02) | (0.04) | (0.07) | (0.06) | (0.09) | (0.06) | (0.07) |
| Net income (loss) per basic share of common stock | 0.38 | 0.56 | 0.16 | (0.04) | 0.13 | 0.12 | 0.72 | 0.25 | 1.10 | 0.21 | 1.42 | 0.45 |
| Diluted net income (loss) per share of common stock: | ||||||||||||
| From continuing operations | 0.40 | 0.57 | 0.19 | (0.02) | 0.18 | 0.14 | 0.76 | 0.32 | 1.15 | 0.29 | 0.41 | 0.52 |
| From discontinued operations | (0.02) | (0.02) | (0.02) | (0.02) | (0.05) | (0.02) | (0.04) | (0.07) | (0.06) | (0.09) | (0.02) | (0.07) |
| Net income (loss) per diluted share of common stock | $ 0.38 | $ 0.55 | $ 0.16 | $ (0.04) | $ 0.13 | $ 0.12 | $ 0.72 | $ 0.25 | $ 1.09 | $ 0.20 | $ 0.40 | $ 0.45 |
| Weighted average number of common shares and common share equivalents outstanding: | ||||||||||||
| Basic | 4,393 | 4,376 | 4,370 | 4,319 | 4,311 | 4,307 | 4,373 | 4,309 | 4,380 | 4,313 | 4,387 | 4,317 |
| Diluted | 4,423 | 4,401 | 4,384 | 4,319 | 4,316 | 4,308 | 4,393 | 4,313 | 4,404 | 4,355 | 15,734 | 4,364 |
| Previously Reported [Member] | ||||||||||||
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||
| Revenue, net | $ 12,295 | $ 12,042 | $ 10,273 | $ 9,078 | $ 11,026 | $ 9,826 | $ 22,314 | $ 20,853 | $ 34,610 | $ 29,931 | $ 40,214 | |
| Cost of revenue | 4,789 | 4,611 | 4,202 | 4,124 | 4,191 | 3,848 | 8,812 | 8,039 | 13,602 | 12,163 | 16,310 | |
| Gross profit | 7,506 | 7,431 | 6,071 | 4,954 | 6,835 | 5,978 | 13,502 | 12,814 | 21,008 | 17,768 | 23,904 | |
| Operating expenses: | ||||||||||||
| Sales and marketing | 2,864 | 2,887 | 2,821 | 2,498 | 2,605 | 2,342 | 5,707 | 4,947 | 8,571 | 7,444 | 10,233 | |
| Research and development | 199 | 146 | 137 | 149 | 186 | 149 | 283 | 335 | 483 | 484 | 636 | |
| General and administrative | 2,538 | 2,141 | 2,239 | 2,124 | 2,894 | 2,494 | 4,381 | 5,389 | 6,918 | 7,515 | 9,363 | |
| Acquisition related amortization expense | 199 | 318 | 318 | 635 | 834 | 861 | ||||||
| Change in fair value of contingent consideration | 7 | |||||||||||
| Total operating expenses | 5,601 | 5,174 | 5,197 | 4,970 | 6,003 | 5,303 | 10,371 | 11,306 | 15,972 | 16,277 | 21,100 | |
| Operating income from continuing operations | 1,905 | 2,257 | 874 | (16) | 832 | 675 | 3,131 | 1,508 | 5,036 | 1,491 | 2,804 | |
| Interest accretion expense | (19) | (35) | (30) | (66) | (34) | (92) | (112) | |||||
| Note payable interest expense | (896) | |||||||||||
| Other expense, net | (667) | |||||||||||
| Income from continuing operations before tax | 1,366 | 2,140 | 576 | (524) | 399 | 434 | 2,716 | 833 | 4,082 | 309 | 1,129 | |
| Provision for income taxes | 4 | 4 | 4 | 4 | 4 | 4 | 8 | 8 | 12 | 12 | 17 | |
| Income from continuing operations | 1,362 | 2,136 | 572 | (528) | 395 | 430 | 2,708 | 825 | 4,070 | 297 | 1,112 | |
| Loss from discontinued operations, net of tax | (82) | (74) | (104) | (86) | (220) | (79) | (178) | (299) | (260) | (385) | (310) | |
| Net income | $ 1,280 | $ 2,062 | $ 468 | $ (614) | $ 175 | $ 351 | $ 2,530 | $ 526 | $ 3,810 | $ (88) | $ 802 | |
| Basic net income (loss) per share of common stock: | ||||||||||||
| From continuing operations | $ 0.31 | $ 0.49 | $ 0.13 | $ (0.12) | $ 0.09 | $ 0.10 | $ 0.62 | $ 0.19 | $ 0.93 | $ 0.07 | $ 0.26 | |
| From discontinued operations | (0.02) | (0.02) | (0.02) | (0.02) | (0.05) | (0.02) | (0.04) | (0.07) | (0.06) | (0.09) | (0.07) | |
| Net income (loss) per basic share of common stock | 0.29 | 0.47 | 0.11 | (0.14) | 0.04 | 0.08 | 0.58 | 0.12 | 0.87 | (0.02) | 0.19 | |
| Diluted net income (loss) per share of common stock: | ||||||||||||
| From continuing operations | 0.31 | 0.49 | 0.13 | (0.12) | 0.09 | 0.10 | 0.62 | 0.19 | 0.92 | 0.07 | 0.25 | |
| From discontinued operations | (0.02) | (0.02) | (0.02) | (0.02) | (0.05) | (0.02) | (0.04) | (0.07) | (0.06) | (0.09) | (0.07) | |
| Net income (loss) per diluted share of common stock | $ 0.29 | $ 0.47 | $ 0.11 | $ (0.14) | $ 0.04 | $ 0.08 | $ 0.58 | $ 0.12 | $ 0.87 | $ (0.02) | $ 0.18 | |
| Weighted average number of common shares and common share equivalents outstanding: | ||||||||||||
| Basic | 4,393 | 4,376 | 4,370 | 4,319 | 4,311 | 4,307 | 4,373 | 4,309 | 4,380 | 4,313 | 4,317 | |
| Diluted | 4,423 | 4,401 | 4,384 | 4,319 | 4,316 | 4,308 | 4,393 | 4,313 | 4,404 | 4,355 | 4,364 | |
| Revision of Prior Period, Reclassification, Adjustment [Member] | ||||||||||||
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||
| Revenue, net | $ (95) | $ 125 | $ 19 | $ (171) | $ (95) | $ (152) | $ (95) | $ (27) | $ (178) | |||
| Cost of revenue | (396) | (375) | (335) | (303) | (365) | (334) | (710) | (699) | (1,106) | (1,002) | (1,330) | |
| Gross profit | 396 | 375 | 240 | 428 | 384 | 163 | 615 | 547 | 1,011 | 975 | 1,152 | |
| Operating expenses: | ||||||||||||
| Sales and marketing | ||||||||||||
| Research and development | ||||||||||||
| General and administrative | ||||||||||||
| Acquisition related amortization expense | ||||||||||||
| Change in fair value of contingent consideration | ||||||||||||
| Total operating expenses | ||||||||||||
| Operating income from continuing operations | 396 | 375 | 240 | 428 | 384 | 163 | 615 | 547 | 1,011 | 975 | 1,152 | |
| Interest accretion expense | ||||||||||||
| Note payable interest expense | ||||||||||||
| Other expense, net | ||||||||||||
| Income from continuing operations before tax | 396 | 375 | 240 | 428 | 384 | 163 | 615 | 547 | 1,011 | 975 | 1,152 | |
| Provision for income taxes | ||||||||||||
| Income from continuing operations | 396 | 375 | 240 | 428 | 384 | 163 | 615 | 547 | 1,011 | 975 | 1,152 | |
| Loss from discontinued operations, net of tax | ||||||||||||
| Net income | $ 396 | $ 375 | $ 240 | $ 428 | $ 384 | $ 163 | $ 615 | $ 547 | $ 1,011 | $ 975 | $ 1,152 | |
| Basic net income (loss) per share of common stock: | ||||||||||||
| From continuing operations | $ 0.09 | $ 0.09 | $ 0.05 | $ 0.10 | $ 0.09 | $ 0.04 | $ 0.14 | $ 0.13 | $ 0.23 | $ 0.23 | $ 0.27 | |
| From discontinued operations | ||||||||||||
| Net income (loss) per basic share of common stock | 0.09 | 0.09 | 0.05 | 0.10 | 0.09 | 0.04 | 0.14 | 0.13 | 0.23 | 0.23 | 0.27 | |
| Diluted net income (loss) per share of common stock: | ||||||||||||
| From continuing operations | 0.09 | 0.09 | 0.05 | 0.10 | 0.09 | 0.04 | 0.14 | 0.13 | 0.23 | 0.22 | 0.26 | |
| From discontinued operations | ||||||||||||
| Net income (loss) per diluted share of common stock | $ 0.09 | $ 0.09 | $ 0.05 | $ 0.10 | $ 0.09 | $ 0.04 | $ 0.14 | $ 0.13 | $ 0.23 | $ 0.22 | $ 0.26 | |
| Weighted average number of common shares and common share equivalents outstanding: | ||||||||||||
| Basic | 4,393 | 4,376 | 4,370 | 4,319 | 4,311 | 4,307 | 4,373 | 4,309 | 4,380 | 4,313 | 4,317 | |
| Diluted | 4,423 | 4,401 | 4,384 | 4,319 | 4,316 | 4,308 | 4,393 | 4,313 | 4,404 | 4,355 | 4,364 | |
| X | ||||||||||
- Definition Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation. No definition available.
|
| X | ||||||||||
- Definition Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation. No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate amount of interest paid or due on all long-term debt. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|